ROCHELLE
PARK, N.J., Nov. 11,
2024 /PRNewswire/ -- Sapiens International
Corporation, (NASDAQ: SPNS) (TASE: SPNS), a leading global provider
of software solutions for the insurance industry, today announced
its financial results for the third quarter ended September 30, 2024.
Summary
Results for Third Quarter 2024 (USD in millions, except
per share data)
|
|
GAAP
|
Non-GAAP
|
|
Q3
2024
|
Q3
2023
|
%
Change
|
Q3
2024
|
Q3
2023
|
%
Change
|
Revenue
|
$137.0
|
$130.7
|
4.8 %
|
$137.0
|
$130.8
|
4.8 %
|
Gross Profit
|
$60.3
|
$56.0
|
7.8 %
|
$62.8
|
$59.3
|
6.0 %
|
Gross Margin
|
44.0 %
|
42.8 %
|
120
bps
|
45.8 %
|
45.3 %
|
50 bps
|
Operating
Income
|
$21.7
|
$20.3
|
7.3 %
|
$25.1
|
$24.1
|
4.3 %
|
Operating
Margin
|
15.9 %
|
15.5 %
|
40 bps
|
18.3 %
|
18.4 %
|
-10 bps
|
Net Income
(*)
|
$18.3
|
$15.9
|
15.5 %
|
$21.1
|
$19.1
|
10.5 %
|
Diluted EPS
|
$0.33
|
$0.28
|
17.9 %
|
$0.37
|
$0.34
|
8.8 %
|
|
(*) Attributable to
Sapiens' shareholders
|
Roni Al-Dor, President and CEO of
Sapiens, stated, "This quarter showcased solid performance in
our key regions. We are pleased to report that revenue reached
$137 million this quarter, reflecting
a 4.8% increase over the same period last year. Revenue growth was
driven by 7.1% growth in our European region, 1.7% growth in
North America and 6.6% growth in
ROW regions. This quarter's non-GAAP operating profit totaled
$25 million, representing 18.3% of
total revenue."
Mr. Al-Dor continued, "Revenue fell short of our targets in the
third quarter, and the challenges we encountered are expected to
impact revenue in the fourth quarter. Today, we are revising our
2024 non-GAAP revenue guidance to a range of $541 million to $546
million, down from the previous range of $550 million to $555
million - a 1.6% reduction at the midpoint. However, we
expect our non-GAAP operating margin to be within our guidance
range at 18.2%. Looking into 2025, we anticipate a low single-digit
revenue growth."
Quarterly Results Conference Call
Management will host a conference call and webcast on
November 11, 2024, at 9:30 a.m. Eastern Time (4:30 p.m. in Israel) to review and discuss Sapiens'
results. Please call the following numbers (at least 10 minutes
before the scheduled time) to participate:
North America (toll-free):
1-888-642-5032
International: 972-3-9180644
UK: 0-800-917-5108
The live webcast of the call can be viewed on Sapiens' website
at: https://veidan.activetrail.biz/sapiensq2-2024. A replay of the
call will be available one business day following the completion of
the event at the same link for 90 days.
Non-GAAP Financial Measures
This press release contains the following non-GAAP financial
measures: non-GAAP revenue, ARR, non-GAAP gross profit, non-GAAP
gross margin, non-GAAP operating income, non-GAAP operating margin,
non-GAAP net income attributed to Sapiens shareholders, non-GAAP
basic and diluted earnings per share, Adjusted EBITDA and Adjusted
Free Cash-Flow.
Sapiens believes that these non-GAAP measures of financial
results provide useful information to management and investors
regarding certain financial and business trends relating to
Sapiens' financial condition and results of operations. The
Company's management uses these non-GAAP measures to compare the
Company's performance to that of prior periods for trend analyses,
for purposes of determining executive and senior management
incentive compensation and for budgeting and planning purposes.
These measures are used in financial reports prepared for
management and in quarterly financial reports presented to the
Company's board of directors. The Company believes that the use of
these non-GAAP financial measures provides an additional tool for
investors to use in evaluating ongoing operating results and
trends, and in comparing the Company's financial measures with
other software companies, many of which present similar non-GAAP
financial measures to investors.
Non-GAAP financial measures consist of GAAP financial measures
adjusted to exclude: Valuation adjustment on acquired deferred
revenue, amortization of capitalized software development and other
intangible assets, capitalization of software development,
stock-based compensation, compensation related to acquisition and
acquisition-related costs, restructuring and cost reduction costs,
and tax adjustments related to non-GAAP adjustments.
Management of the Company does not consider these non-GAAP
measures in isolation, or as an alternative to financial measures
determined in accordance with GAAP. The principal limitation of
these non-GAAP financial measures is that they exclude significant
expenses and income that are required by GAAP to be recorded in the
Company's financial statements. In addition, they are subject to
inherent limitations, as they reflect the exercise of judgment by
management about which expenses and income are excluded or included
in determining these non-GAAP financial measures.
To compensate for these limitations, management presents
non-GAAP financial measures in connection with GAAP results.
Sapiens urges investors to review the reconciliation of its
non-GAAP financial measures to the comparable GAAP financial
measures, which it includes in press releases announcing quarterly
financial results, including this press release, and not to rely on
any single financial measure to evaluate the Company's
business.
Reconciliation tables of the most comparable GAAP financial
measures to the non-GAAP financial measures used in this press
release are included with the financial tables of this release.
The Company defines Annual Recurring Revenue ("ARR") as the
annualized value of our revenue from customer subscriptions, term
licenses, maintenance, application maintenance, and cloud
solutions, which may not be the same as the timing and amount of
revenue recognized. The ARR run rate is equal to the product of (i)
the sum of these revenues in our most recently completed fiscal
quarter, multiplied by (ii) four.
The Company defines Adjusted EBITDA as net profit,
adjusted to eliminate valuation adjustment on acquired deferred
revenue, stock-based compensation expense, depreciation and
amortization, capitalization of software development costs,
compensation expenses related to acquisition and
acquisition-related costs, restructuring and cost reduction costs,
financial expense (income), provision for income taxes and other
income (expenses). These amounts are often excluded by other
companies as well, in order to help investors understand the
operational performance of their business.
The Company uses Adjusted EBITDA as a measurement of its
operating performance, because it assists in comparing the
operating performance on a consistent basis by removing the impact
of certain non-cash and non-operating items. Adjusted EBITDA
reflects an additional way of viewing aspects of the operations
that the Company believes, when viewed with the GAAP results and
the accompanying reconciliations to corresponding GAAP financial
measures, provide a more complete understanding of factors and
trends affecting its business. The Company uses Adjusted Free
Cash-Flow as a measurement of its operating performance, and
reconciles cash-flow from operating activities to Adjusted Free
Cash-Flow, while reducing the amounts for capitalization of
software development costs and capital expenditures. The Company
adds back cash payments made for former acquisitions in respect of
future performance targets and retention criteria as determined
upon acquisition date of the respective acquired company, which
were included in the cash-flow from operating activities. We
believe that Adjusted Free Cash-Flow is useful in evaluating our
business, because Adjusted Free Cash-Flow reflects the cash surplus
available to fund the expansion of our business.
About Sapiens
Sapiens International Corporation (NASDAQ and TASE: SPNS) is a
global leader in intelligent insurance software solutions. With
Sapiens' robust platform, customer-driven partnerships, and rich
ecosystem, insurers are empowered to future-proof their
organizations with operational excellence in a rapidly changing
marketplace. We help insurers harness the power of AI and advanced
automation to support core solutions for property and casualty,
workers' compensation, and life insurance, including reinsurance,
financial & compliance, data & analytics, digital, and
decision management. Sapiens boasts a longtime global presence,
serving over 600 customers in more than 30 countries with its
innovative SaaS offerings. Recognized by industry experts and
selected for the Microsoft Top 100 Partner program, Sapiens is
committed to partnering with our customers for their entire
transformation journey and is continuously innovating to ensure
their success.
Investor and Media
Contact
Yaffa
Cohen-Ifrah
Chief Marketing Officer
and Head of
Investor Relations,
Sapiens
Yaffa.cohen-ifrah@sapiens.com
+1
917-533-4782
|
Investor
Contacts
Brett Maas
Managing
Partner, Hayden IR
+1
646-536-7331
Brett.Maas@HaydenIR.com
Kimberly
Rogers
Managing
Director, Hayden IR
+1
541-904-5075
kim@HaydenIR.com
|
Forward Looking Statements
Certain matters discussed in this press release that are
incorporated herein and therein by reference are forward-looking
statements within the meaning of Section 27A of the Securities Act,
Section 21E of the Exchange Act and the safe harbor provisions of
the U.S. Private Securities Litigation Reform Act of 1995, that are
based on our beliefs, assumptions and expectations, as well as
information currently available to us. Such forward-looking
statements may be identified by the use of the words "anticipate,"
"believe," "estimate," "expect," "may," "will," "plan" and similar
expressions. Such statements reflect our current views with respect
to future events and are subject to certain risks and
uncertainties. There are important factors that could cause our
actual results, levels of activity, performance or achievements to
differ materially from the results, levels of activity, performance
or achievements expressed or implied by the forward-looking
statements, including, but not limited to: the degree of our
success in our plans to leverage our global footprint to grow our
sales; the degree of our success in integrating the companies that
we have acquired through the implementation of our M&A growth
strategy; the lengthy development cycles for our solutions, which
may frustrate our ability to realize revenues and/or profits from
our potential new solutions; our lengthy and complex sales cycles,
which do not always result in the realization of revenues; the
degree of our success in retaining our existing customers or
competing effectively for greater market share; the global
macroeconomic environment, including headwinds caused by inflation,
relatively high interest rates, potentially unfavorable currency
exchange rate movements, and uncertain economic conditions, and
their impact on our revenues, profitability and cash flows;
difficulties in successfully planning and managing changes in the
size of our operations; the frequency of the long-term, large,
complex projects that we perform that involve complex estimates of
project costs and profit margins, which sometimes change
mid-stream; the challenges and potential liability that heightened
privacy laws and regulations pose to our business; occasional
disputes with clients, which may adversely impact our results of
operations and our reputation; various intellectual property issues
related to our business; potential unanticipated product
vulnerabilities or cybersecurity breaches of our or our customers'
systems; risks related to the insurance industry in which our
clients operate; risks associated with our global sales and
operations, such as changes in regulatory requirements, wide-spread
viruses and epidemics like the coronavirus epidemic, and
fluctuations in currency exchange rates; and risks related to our
principal location in Israel and
our status as a Cayman Islands
company.
While we believe such forward-looking statements are based on
reasonable assumptions, should one or more of the underlying
assumptions prove incorrect, or these risks or uncertainties
materialize, our actual results may differ materially from those
expressed or implied by the forward-looking statements. Please read
the risks discussed under the heading "Risk Factors" in our Annual
Report on Form 20-F for the year ended December 31, 2023, to be filed in the near
future, in order to review conditions that we believe could cause
actual results to differ materially from those contemplated by the
forward-looking statements. You should not rely upon
forward-looking statements as predictions of future events.
Although we believe that the expectations reflected in the
forward-looking statements are reasonable, we cannot guarantee that
future results, levels of activity, performance and events and
circumstances reflected in the forward-looking statements will be
achieved or will occur. Except as required by law, we undertake no
obligation to update publicly any forward-looking statements for
any reason, to conform these statements to actual results or to
changes in our expectations.
|
SAPIENS
INTERNATIONAL CORPORATION N.V. AND ITS
SUBSIDIARIES
CONDENSED
CONSOLIDATED STATEMENT OF
INCOME
U.S. dollars in
thousands (except per share amounts)
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
|
September
30,
|
|
September
30,
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
|
Revenue
|
|
137,025
|
|
130,705
|
|
408,074
|
|
383,725
|
Cost of
revenue
|
|
76,729
|
|
74,753
|
|
230,114
|
|
220,080
|
|
|
|
|
|
|
|
|
|
|
Gross
profit
|
|
60,296
|
|
55,952
|
|
177,960
|
|
163,645
|
|
|
|
|
|
|
|
|
|
|
Operating
expenses:
|
|
|
|
|
|
|
|
|
|
Research and
development, net
|
|
16,449
|
|
16,028
|
|
49,779
|
|
47,391
|
|
Selling,
marketing, general and administrative
|
|
22,101
|
|
19,659
|
|
64,030
|
|
57,475
|
Total operating
expenses
|
|
38,550
|
|
35,687
|
|
113,809
|
|
104,866
|
|
|
|
|
|
|
|
|
|
|
Operating
income
|
|
21,746
|
|
20,265
|
|
64,151
|
|
58,779
|
|
|
|
|
|
|
|
|
|
|
Financial and
other (income) expenses, net
|
|
(913)
|
|
551
|
|
(3,114)
|
|
2,310
|
Taxes on
income
|
|
4,324
|
|
3,710
|
|
12,812
|
|
10,627
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net
income
|
|
18,335
|
|
16,004
|
|
54,453
|
|
45,842
|
|
|
|
|
|
|
|
|
|
|
Attributable to
non-controlling interest
|
|
-
|
|
132
|
|
141
|
|
371
|
|
|
|
|
|
|
|
|
|
|
Net income
attributable to Sapiens' shareholders
|
|
18,335
|
|
15,872
|
|
54,312
|
|
45,471
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings
per share
|
|
0.33
|
|
0.29
|
|
0.97
|
|
0.82
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings
per share
|
|
0.33
|
|
0.28
|
|
0.97
|
|
0.82
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number
of shares outstanding used to
compute basic earnings per share (in thousands)
|
|
55,854
|
|
55,397
|
|
55,799
|
|
55,251
|
|
|
|
|
|
|
|
|
|
Weighted average number
of shares outstanding used to
compute diluted earnings per share (in thousands)
|
|
56,308
|
|
55,813
|
|
56,151
|
|
55,657
|
SAPIENS
INTERNATIONAL CORPORATION N.V. AND
SUBSIDIARIES
RECONCILIATION OF
GAAP TO NON-GAAP RESULTS
U.S. dollars in
thousands (except per share amounts)
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
September
30,
|
|
September
30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
|
|
|
|
|
|
GAAP revenue
|
|
137,025
|
|
130,705
|
|
408,074
|
|
383,725
|
Valuation adjustment on
acquired deferred
revenue
|
|
-
|
|
55
|
|
-
|
|
165
|
Non-GAAP
revenue
|
|
137,025
|
|
130,760
|
|
408,074
|
|
383,890
|
|
|
|
|
|
|
|
|
|
GAAP gross
profit
|
|
60,296
|
|
55,952
|
|
177,960
|
|
163,645
|
Revenue
adjustment
|
|
-
|
|
55
|
|
-
|
|
165
|
Amortization of
capitalized software
|
|
1,470
|
|
1,418
|
|
4,584
|
|
4,274
|
Amortization of other
intangible assets
|
|
1,043
|
|
1,835
|
|
3,630
|
|
5,531
|
Non-GAAP gross
profit
|
|
62,809
|
|
59,260
|
|
186,174
|
|
173,615
|
|
|
|
|
|
|
|
|
|
GAAP operating
income
|
|
21,746
|
|
20,265
|
|
64,151
|
|
58,779
|
Gross profit
adjustments
|
|
2,513
|
|
3,308
|
|
8,214
|
|
9,970
|
Capitalization of
software development
|
|
(1,834)
|
|
(1,638)
|
|
(5,374)
|
|
(4,975)
|
Amortization of other
intangible assets
|
|
1,276
|
|
1,074
|
|
3,732
|
|
3,234
|
Stock-based
compensation
|
|
646
|
|
1,038
|
|
2,229
|
|
2,960
|
Acquisition-related
costs *)
|
|
754
|
|
11
|
|
1,248
|
|
21
|
Non-GAAP operating
income
|
|
25,101
|
|
24,058
|
|
74,200
|
|
69,989
|
|
|
|
|
|
|
|
|
|
GAAP net income
attributable to Sapiens'
shareholders
|
|
18,335
|
|
15,872
|
|
54,312
|
|
45,471
|
Operating income
adjustments
|
|
3,355
|
|
3,793
|
|
10,049
|
|
11,210
|
Taxes on
income
|
|
(599)
|
|
(585)
|
|
(1,808)
|
|
(1,738)
|
Non-GAAP net
income attributable to Sapiens'
shareholders
|
|
21,091
|
|
19,080
|
|
62,553
|
|
54,943
|
(*)
Acquisition-related costs pertain to charges on behalf of M&A
agreements related to future performance targets and retention
criteria, as well as completed or prospective third-party services,
such as tax, accounting and legal rendered.
|
Adjusted EBITDA
Calculation
U.S. dollars in
thousands
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
September
30,
|
|
September
30,
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
|
GAAP operating
profit
|
|
21,746
|
|
20,265
|
|
64,151
|
|
58,779
|
|
|
|
|
|
|
|
|
|
Non-GAAP
adjustments:
|
|
|
|
|
|
|
|
|
Valuation adjustment on
acquired deferred revenue
|
|
-
|
|
55
|
|
-
|
|
165
|
Amortization of
capitalized software
|
|
1,470
|
|
1,418
|
|
4,584
|
|
4,274
|
Amortization of other
intangible assets
|
|
2,319
|
|
2,909
|
|
7,362
|
|
8,765
|
Capitalization of
software development
|
|
(1,834)
|
|
(1,638)
|
|
(5,374)
|
|
(4,975)
|
Stock-based
compensation
|
|
646
|
|
1,038
|
|
2,229
|
|
2,960
|
Compensation related to
acquisition and acquisition-related costs
|
|
754
|
|
11
|
|
1,248
|
|
21
|
|
|
|
|
|
|
|
|
|
Non-GAAP operating
profit
|
|
25,101
|
|
24,058
|
|
74,200
|
|
69,989
|
|
|
|
|
|
|
|
|
|
Depreciation
|
|
1,288
|
|
719
|
|
3,480
|
|
2,750
|
|
|
|
|
|
|
|
|
|
Adjusted
EBITDA
|
|
26,389
|
|
24,777
|
|
77,680
|
|
72,739
|
Summary of NON-GAAP
Financial Information
U.S. dollars in
thousands (except per share amounts)
|
|
|
Q3
2024
|
|
Q2
2024
|
|
Q1
2024
|
|
Q4
2023
|
|
Q3
2023
|
|
|
|
|
|
|
|
|
|
|
Revenues
|
137,025
|
|
136,800
|
|
134,249
|
|
130,914
|
|
130,760
|
Gross profit
|
62,809
|
|
62,481
|
|
60,884
|
|
59,370
|
|
59,260
|
Operating
income
|
25,101
|
|
24,836
|
|
24,263
|
|
24,152
|
|
24,058
|
Adjusted
EBITDA
|
26,389
|
|
25,931
|
|
25,360
|
|
25,267
|
|
24,777
|
Net income to Sapiens'
shareholders
|
21,091
|
|
21,041
|
|
20,421
|
|
20,081
|
|
19,080
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per
share
|
0.37
|
|
0.37
|
|
0.36
|
|
0.36
|
|
0.34
|
Annual Recurring
Revenue ("ARR")
U.S. dollars in
thousands
|
|
|
|
|
Three months
ended
|
|
|
September
30,
|
|
|
2024
|
|
|
2023
|
|
Annual Recurring Revenue
|
|
173,414
|
|
|
|
157,589
|
|
|
|
|
|
|
|
|
|
Non-GAAP Revenues by
Geographic Breakdown
U.S. dollars in
thousands
|
|
Q3 2024
|
|
Q2 2024
|
|
Q1 2024
|
|
Q4 2023
|
|
Q3 2023
|
|
|
|
|
|
|
|
|
|
|
North
America
|
55,755
|
|
57,918
|
|
55,158
|
|
54,882
|
|
54,848
|
Europe
|
69,281
|
|
66,072
|
|
68,727
|
|
65,239
|
|
64,662
|
Rest of the
World
|
11,989
|
|
12,810
|
|
10,364
|
|
10,793
|
|
11,250
|
|
|
|
|
|
|
|
|
|
|
Total
|
137,025
|
|
136,800
|
|
134,249
|
|
130,914
|
|
130,760
|
|
|
|
Non-GAAP Revenue breakdown
|
|
|
U.S. dollars in
thousands
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
|
September
30,
|
|
September
30,
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
Software products and
re-occurring post-production services (*)
|
100,707
|
|
87,356
|
|
292,992
|
|
251,757
|
|
|
Pre-production
implementation services (**)
|
36,318
|
|
43,404
|
|
115,082
|
|
132,133
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
Revenues
|
137,025
|
|
130,760
|
|
408,074
|
|
383,890
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
|
|
September
30,
|
|
September
30,
|
|
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
|
|
|
|
Software products and
re-occurring post-production services (*)
|
53,809
|
|
46,053
|
|
156,386
|
|
133,339
|
|
|
Pre-production
implementation services (**)
|
9,000
|
|
13,207
|
|
29,788
|
|
40,276
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Gross
profit
|
62,809
|
|
59,260
|
|
186,174
|
|
173,615
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months
ended
|
|
Nine months
ended
|
|
September
30,
|
|
September
30,
|
|
2024
|
|
2023
|
|
2024
|
|
2023
|
|
|
|
|
|
|
|
|
Software products and
re-occurring post-production services (*)
|
53.4 %
|
|
52.7 %
|
|
53.4 %
|
|
53.0 %
|
Pre-production
implementation services (**)
|
24.8 %
|
|
30.4 %
|
|
25.9 %
|
|
30.5 %
|
|
|
|
|
|
|
|
|
Gross
Margin
|
45.8 %
|
|
45.3 %
|
|
45.6 %
|
|
45.2 %
|
|
(*) Software products
and re-occurring post-production services include mainly
subscription, term license, maintenance, application maintenance,
cloud solutions and post-production services. This revenue stream
is a mix of recurring and re-occurring in nature.
(**) Pre-production implementation services include mainly
implementation services before go-live, which are one-time in
nature.
|
Adjusted Free
Cash-Flow
U.S. dollars in
thousands
|
|
|
Q3
2024
|
|
Q2
2024
|
|
Q1
2024
|
|
Q4
2023
|
|
Q3
2023
|
|
|
|
|
|
|
|
|
|
|
Cash-flow from
operating activities
|
13,083
|
|
8,545
|
|
18,488
|
|
38,646
|
|
3,988
|
Increase in capitalized
software development costs
|
(1,834)
|
|
(1,823)
|
|
(1,717)
|
|
(1,543)
|
|
(1,638)
|
Capital
expenditures
|
(1,125)
|
|
(666)
|
|
(466)
|
|
(421)
|
|
(696)
|
Free
cash-flow
|
10,124
|
|
6,056
|
|
16,305
|
|
36,682
|
|
1,654
|
|
|
|
|
|
|
|
|
|
|
Cash payments
attributed to acquisition-related costs(*)
(**)
|
124
|
|
134
|
|
751
|
|
221
|
|
-
|
|
|
|
|
|
|
|
|
|
|
Adjusted free
cash-flow
|
10,248
|
|
6,190
|
|
17,056
|
|
36,903
|
|
1,654
|
(*) Included in
cash-flow from operating activities
(**) Acquisition-related payments pertain to charges on behalf
of M&A agreements related to future performance
targets and retention criteria, as well as completed or
prospective third-party services, such as tax, accounting and legal
rendered.
|
SAPIENS
INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES
CONDENSED CONSOLIDATED
BALANCE SHEET
U.S. dollars in
thousands
|
|
|
|
|
|
September
30,
|
|
December
31,
|
|
|
|
2024
|
|
2023
|
|
|
|
(unaudited)
|
|
(unaudited)
|
|
|
|
|
|
|
ASSETS
|
|
|
|
|
|
|
|
|
|
|
|
CURRENT
ASSETS
|
|
|
|
|
|
Cash and cash
equivalents
|
|
146,152
|
|
126,716
|
|
Short-term bank
deposit
|
|
39,800
|
|
75,400
|
|
Trade receivables, net
and unbilled receivables
|
|
109,670
|
|
90,273
|
|
Other receivables and
prepaid expenses
|
|
25,769
|
|
22,514
|
|
|
|
|
|
|
|
Total current
assets
|
|
321,391
|
|
314,903
|
|
|
|
|
|
|
LONG-TERM
ASSETS
|
|
|
|
|
|
Property and equipment,
net
|
|
11,431
|
|
12,661
|
|
Severance pay
fund
|
|
3,446
|
|
3,605
|
|
Goodwill and intangible
assets, net
|
|
310,533
|
|
317,352
|
|
Operating lease
right-of-use assets
|
|
20,502
|
|
23,557
|
|
Other long-term
assets
|
|
15,993
|
|
17,546
|
|
|
|
|
|
|
|
Total long-term
assets
|
|
361,905
|
|
374,721
|
|
|
|
|
|
|
TOTAL
ASSETS
|
|
683,296
|
|
689,624
|
|
|
|
|
|
|
LIABILITIES AND
EQUITY
|
|
|
|
|
|
|
|
|
|
|
CURRENT
LIABILITIES
|
|
|
|
|
|
Trade
payables
|
|
8,224
|
|
6,291
|
|
Current maturities of
Series B Debentures
|
|
19,796
|
|
19,796
|
|
Accrued expenses and
other liabilities
|
|
80,610
|
|
77,873
|
|
Current maturities of
operating lease liabilities
|
|
5,861
|
|
6,623
|
|
Deferred
revenue
|
|
32,810
|
|
38,541
|
|
|
|
|
|
|
|
Total current
liabilities
|
|
147,301
|
|
149,124
|
|
|
|
|
|
|
LONG-TERM
LIABILITIES
|
|
|
|
|
|
Series B Debentures,
net of current maturities
|
|
19,778
|
|
39,543
|
|
Deferred tax
liabilities
|
|
7,938
|
|
10,820
|
|
Other long-term
liabilities
|
|
11,399
|
|
11,538
|
|
Long-term operating
lease liabilities
|
|
17,532
|
|
21,084
|
|
Accrued severance
pay
|
|
8,039
|
|
7,568
|
|
|
|
|
|
|
|
Total long-term
liabilities
|
|
64,686
|
|
90,553
|
|
|
|
|
|
|
EQUITY
|
|
|
471,309
|
|
449,947
|
|
|
|
|
|
|
TOTAL LIABILITIES
AND EQUITY
|
|
683,296
|
|
689,624
|
|
|
|
|
|
SAPIENS
INTERNATIONAL CORPORATION N.V. AND ITS SUBSIDIARIES
CONSOLIDATED
STATEMENT OF CASH FLOW
U.S. dollars in
thousands
|
|
|
For the nine
months ended
September 30,
|
|
2024
|
|
2023
|
|
(unaudited)
|
|
(unaudited)
|
Cash flows from
operating activities:
|
|
|
|
Net income
|
54,453
|
|
45,842
|
Reconciliation of net
income to net cash provided by operating activities:
|
|
|
|
Depreciation
|
3,480
|
|
2,750
|
Amortization of
capitalized software and other intangible assets
|
11,946
|
|
13,039
|
Accretion of discount
on Series B Debentures
|
32
|
|
47
|
Capital loss from sale
of property and equipment
|
13
|
|
83
|
Stock-based
compensation related to options issued to employees
|
2,229
|
|
2,960
|
|
|
|
|
Net changes in
operating assets and liabilities, net of amount
acquired:
|
|
|
|
Increase in trade
receivables, net and unbilled receivables
|
(20,640)
|
|
(8,698)
|
Decrease in deferred
tax liabilities, net
|
(2,280)
|
|
(1,410)
|
Increase in other
operating assets
|
(908)
|
|
(4,107)
|
Increase (decrease) in
trade payables
|
1,989
|
|
(616)
|
Decrease in other
operating liabilities
|
(5,154)
|
|
(10,110)
|
Increase (decrease) in
deferred revenues
|
(5,684)
|
|
363
|
Increase in accrued
severance pay, net
|
640
|
|
636
|
|
|
|
|
Net cash provided by
operating activities
|
40,116
|
|
40,779
|
|
|
|
|
Cash flows from
investing activities:
|
|
|
|
Purchase of property
and equipment
|
(2,306)
|
|
(2,145)
|
Proceeds from
(investment in) deposits
|
36,360
|
|
(55,379)
|
Proceeds from sale of
property and equipment
|
49
|
|
40
|
Payments for business
acquisitions, net of cash acquired
|
(375)
|
|
-
|
Capitalized software
development costs
|
(5,374)
|
|
(4,975)
|
Acquisition of
intellectual property
|
-
|
|
(177)
|
|
|
|
|
Net cash provided by
(used in) investing activities
|
28,354
|
|
(62,636)
|
|
|
|
|
Cash flows from
financing activities:
|
|
|
|
Proceeds from employee
stock options exercised
|
98
|
|
4,755
|
Distribution of
dividend
|
(29,789)
|
|
(28,144)
|
Repayment of Series B
Debenture
|
(19,796)
|
|
(19,796)
|
Acquisition of
non-controlling interest
|
(4,131)
|
|
-
|
Dividend to
non-controlling interest
|
-
|
|
(47)
|
|
|
|
|
Net cash used in
financing activities
|
(53,618)
|
|
(43,232)
|
|
|
|
|
Effect of exchange
rate changes on cash and cash equivalents
|
4,584
|
|
1,865
|
|
|
|
|
Increase (decrease) in
cash and cash equivalents
|
19,436
|
|
(63,224)
|
Cash and cash
equivalents at the beginning of period
|
126,716
|
|
160,285
|
|
|
|
|
Cash and cash
equivalents at the end of period
|
146,152
|
|
97,061
|
Debentures Covenants
As of September 30, 2024, Sapiens
was in compliance with all of its financial covenants under the
indenture for the Series B Debentures, based on having achieved the
following in its consolidated financial results:
Covenant 1
- Target shareholders' equity (excluding non-controlling
interest): above $120 million.
- Actual shareholders' equity (excluding non-controlling
interest) equal to $471.3
million.
Covenant 2
- Target ratio of net financial indebtedness to net
capitalization (in each case, as defined under the indenture for
the Company's Series B Debentures) below 65%.
- Actual ratio of net financial indebtedness to net
capitalization equal to (44.90)%.
Covenant 3
- Target ratio of net financial indebtedness to EBITDA
(accumulated calculation for the four last quarters) is below
5.5.
- Actual ratio of net financial indebtedness to EBITDA
(accumulated calculation for the four last quarters) is equal to
(1.42).
Logo:
https://mma.prnewswire.com/media/585787/Sapiens_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/sapiens-reports-third-quarter-2024-financial-results-302301087.html
SOURCE Sapiens International Corporation